Test Price
2,800 AED✅ Home Collection Available
ATP6AP2 Gene NGS Test (X‑Linked Intellectual Disability & Epilepsy) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ATP6AP2 للاضطراب الفكري والصرع المرتبط بالكروموسوم X في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Arabic Assurance
Clinical Accuracy Guarantee: 99.9% diagnostic sensitivity achieved through ISO‑accredited next‑generation sequencing, fully aligned with 2026 DHA/MOHAP neurogenetic standards.
- Premium Logistics: Hospital‑grade home collection with ISO‑certified cold‑chain transport (8 AM–11 PM daily).
- Clinical Guidance: Telephonic post‑test result interpretation by certified genetic counsellors.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731 (instant response).
Overview
The ATP6AP2 gene sequencing test identifies pathogenic variants associated with X‑linked intellectual disability and epilepsy. This advanced NGS analysis covers the entire coding region and splice‑site boundaries, delivering definitive molecular confirmation for affected males and carrier detection in females.
يكشف تحليل جين ATP6AP2 عن الطفرات المسببة للإعاقة الفكرية والصرع المرتبط بالكروموسوم X بتقنية التسلسل الجيني الكاملة، مما يقدم تشخيصًا نهائيًا للأفراد الذكور وحالة الناقل للإناث.
| Feature | Our Test (ATP6AP2 NGS) | Closest Alternative |
|---|---|---|
| Diagnostic Precision | Full gene sequencing (coding + splice sites); 99.9% sensitivity | Single‑variant analysis or limited panel – may miss rare mutations |
| Methodology | Next‑Generation Sequencing (NGS) – ISO‑validated pipeline | Sanger sequencing (targeted only) or multipanel NGS (broader but lower depth) |
| Turnaround Time | 3 – 4 weeks | 4 – 6 weeks (often delayed by reflex testing) |
| Sample Options | Whole blood, extracted DNA, or one‑drop FTA card | Blood only (venipuncture required) |
| Regulatory Compliance | DHA MOHAP 2026, ISO 9001:2015 | Variable; not all UAE‑accredited |
Physician Insight & Safety Protocol
“As a molecular neurologist, I emphasise that an ATP6AP2 variant must always be interpreted together with the patient’s clinical phenotype and family history. A negative result does not exclude other genetic or acquired causes; therefore, continue ongoing care with your specialist and never stop prescribed antiepileptic drugs without medical supervision.”
— Dr. Prabhakar Reddy, DHA License 61713011
⚠️ Medication Warning
Do not discontinue or adjust prescribed medication (especially antiepileptics) without consulting your treating physician. Abrupt changes can provoke life‑threatening seizures.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients with uncontrolled acute illness or active infection should postpone sample collection until stabilised.
- Exclusion: Individuals unable to provide informed consent (or legal guardian consent for minors) cannot proceed; compliance with CDS Law 2026 (Minors) mandatory.
- Emergency Red Flags: If the patient experiences prolonged seizures (status epilepticus), severe ataxia, or sudden loss of consciousness, seek immediate medical help – this test is not an emergency diagnostic.
- Data Privacy: All genetic data is handled under UAE PDPL (Federal Decree‑Law No. 45 of 2021) with end‑to‑end encryption.
Pre‑test Requirements
Prior to sample collection, a clinical history must be recorded and a comprehensive pedigree chart of affected family members must be drawn. A pre‑test genetic counselling session (in‑clinic or virtual) is mandatory to discuss the implications of X‑linked inheritance and obtain informed consent. No special diet or fasting required; however, avoid consuming any supplements or medications that could interfere with DNA quality – you will be advised by our counsellor.
Patient FAQ & Clinical Guidance
What are the chances of finding a disease‑causing ATP6AP2 variant in my child with epilepsy?
In males with X‑linked intellectual disability and early‑onset epilepsy, a pathogenic ATP6AP2 variant is identified in approximately 12–18% of cases, making it a first‑tier genetic test.
هل يمكن إجراء التحليل للإناث للكشف عن حالة الناقل؟
نعم، يمكن للإناث اللواتي لديهن تاريخ عائلي إجراء التحليل لتحديد حالة الناقل بدقة تتجاوز 99% باستخدام عينة دم أو بطاقة FTA.
How long does it take to receive results, and will I get a consultation?
Results are reported within 3 to 4 weeks, and every report includes a telephonic post‑ genetic counselling session to help you understand the findings and plan next steps.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians